Floatz logo

Anti-Cd19/20-Car Vector-Transduced T Cells

Adult Acute Lymphoblastic Leukemia in Remission

Chinese PLA General HospitalCell therapyPhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Adult Acute Lymphoblastic Leukemia in Remission cohort.

Asset / SponsorPhaseRating
METHOTREXATE
PETHEMA Foundation
Phase 4BBB
Cyclophosphamide
The First Affiliated Hospital of Zhengzhou University
Phase 4BBB
Fludarabine
Northside Hospital, Inc.
Phase 4BBB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2BBB
Busulphan
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 2/3BB

View all 38 →

Same molecule, other indications

Anti-Cd19/20-Car Vector-Transduced T Cells is also rated in:

B Cell LymphomaDormant
CCC
Indicative ·
53 / 100
View asset →
Hematopoietic/Lymphoid CancerDormant
CCC
Indicative ·
52 / 100
View asset →
B-cell Adult Acute Lymphoblastic LeukemiaDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →